Boston Scientific to expand CRM footprint with Cameron Health buy

03/8/2012 | Wall Street Journal, The

Boston Scientific hopes to strengthen its foothold in the cardiac rhythm management market with the acquisition of Cameron Health, maker of the S-ICD wireless defibrillator. The deal calls for Boston Scientific to pay $150 million upfront in cash and possibly $150 million more upon FDA approval of the S-ICD system, plus as much as $1.05 billion in potential milestone payments during the course of the six years immediately after FDA approval.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA